Cargando…

A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma

BACKGROUND: The prognosis of hepatocellular carcinoma (HCC) patients remains poor. Identifying prognostic markers to stratify HCC patients might help to improve their outcomes. METHODS: Six gene expression profiles (GSE121248, GSE84402, GSE65372, GSE51401, GSE45267 and GSE14520) were obtained for di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ouyang, Guoqing, Yi, Bin, Pan, Guangdong, Chen, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268417/ https://www.ncbi.nlm.nih.gov/pubmed/32514252 http://dx.doi.org/10.1186/s12935-020-01294-9

Ejemplares similares

An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients
por: Zhu, Gongmin, et al.
Publicado: (2021)

A novel tumor doubling time-related immune gene signature for prognosis prediction in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2021)

Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
por: Hu, Yinan, et al.
Publicado: (2022)

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
por: Bu, Xiaoyun, et al.
Publicado: (2022)

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
por: Zheng, Qiuxian, et al.
Publicado: (2021)

Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma
por: Shi, Jinyuan, et al.
Publicado: (2021)

Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
por: Liu, Gao-Min, et al.
Publicado: (2019)

Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma
por: She, Yangyang, et al.
Publicado: (2020)

A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration
por: Luan, Jiao-chen, et al.
Publicado: (2021)

Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
por: Zhou, Cankun, et al.
Publicado: (2020)

Identification of a 6-gene signature predicting prognosis for colorectal cancer
por: Zuo, Shuguang, et al.
Publicado: (2019)

Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma
por: Guo, Lingyun, et al.
Publicado: (2020)

Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma
por: Yan, Tao, et al.
Publicado: (2019)

Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
por: Peng, Yanan, et al.
Publicado: (2021)

Expression of the Wnt ligands gene family and its relationship to prognosis in hepatocellular carcinoma
por: Dong, Jia-Jia, et al.
Publicado: (2019)

Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma
por: Cai, Weiyang, et al.
Publicado: (2021)

Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis
por: Chen, Qian, et al.
Publicado: (2021)

Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer
por: Zhu, Ke, et al.
Publicado: (2021)

Two predictive precision medicine tools for hepatocellular carcinoma
por: Zhang, Zhiqiao, et al.
Publicado: (2019)

Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma
por: Sun, Xiang-Hong, et al.
Publicado: (2020)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
por: Wang, Yi, et al.
Publicado: (2021)

Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer
por: Yu, Jing, et al.
Publicado: (2021)

Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma
por: Liu, Jiahua, et al.
Publicado: (2021)

Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer
por: Liang, Leilei, et al.
Publicado: (2022)

The Pyroptosis-Related Gene Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Shuqiao, et al.
Publicado: (2022)

Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma
por: Xue, Chen, et al.
Publicado: (2021)

Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma
por: Qin, Yuan, et al.
Publicado: (2022)

Identification of a m(6)A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma
por: Chen, Jing, et al.
Publicado: (2020)

Spatial maps of hepatocellular carcinoma transcriptomes highlight an unexplored landscape of heterogeneity and a novel gene signature for survival
por: Zhao, Nan, et al.
Publicado: (2022)

UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2020)

BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma
por: Li, Yibing, et al.
Publicado: (2020)

Prognostic signature composed of transcription factors accurately predicts the prognosis of gastric cancer patients
por: Zhou, Liqiang, et al.
Publicado: (2021)

Development and validation of robust metabolism‐related gene signature in the prognostic prediction of hepatocellular carcinoma
por: Pan, Yangxun, et al.
Publicado: (2023)

A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer
por: Wu, Jin, et al.
Publicado: (2022)

A new risk score based on twelve hepatocellular carcinoma-specific gene expression can predict the patients’ prognosis
por: Lin, Ting, et al.
Publicado: (2018)

Twelve Years of National Football League Concussion Data
por: Casson, Ira R., et al.
Publicado: (2010)

Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
por: Lv, Lei, et al.
Publicado: (2020)

A signature of hypoxia-related factors reveals functional dysregulation and robustly predicts clinical outcomes in stage I/II colorectal cancer patients
por: Zou, Yi-feng, et al.
Publicado: (2019)

A novel immune signature to predict the prognosis of patients with hepatocellular carcinoma
por: Li, Qinghe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_94i23sqsqhmbkegd4fbpfnqh2k